Pharmaceutical

Announcement Regarding Completion of FDA IND Review and Approval to Include U.S. Sites and Patients in the ICEF15 Multi-Regional Phase III Trial

Announcement Regarding Completion of FDA IND Review and Approval to Include U.S. Sites and Patients in the ICEF15 Multi-Regional Phase III Trial

articleInnovacell Inc.July 2, 20264/news/announcement-regarding-completion-of-fda-ind-review-and-approval-to-include-us-sites-and-patients-in-the-icef15-multi-regional-phase-iii-trial
Announcement Regarding Completion of FDA IND Review and Approval to Include U.S. Sites and Patients in the ICEF15 Multi-Regional Phase III Trial

About this update from Innovacell Inc.

Innovacell Inc. (504A) Press ReleaseView Attachment

View stock analysis, news, and events for Innovacell Inc.